CellBion Co., Ltd. (KOSDAQ:308430)
23,100
+400 (1.76%)
At close: Jan 16, 2026
48.17% (1Y)
| Market Cap | 286.78B |
| Revenue (ttm) | 2.13B |
| Net Income (ttm) | -7.55B |
| Shares Out | 12.83M |
| EPS (ttm) | -589.39 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 172,525 |
| Average Volume | 146,147 |
| Open | 22,300 |
| Previous Close | 22,700 |
| Day's Range | 22,000 - 24,100 |
| 52-Week Range | 12,770 - 29,600 |
| Beta | n/a |
| RSI | 48.28 |
| Earnings Date | Mar 30, 2026 |